Anemia, Megaloblastic




Risk





  • Prevalence: Estimates ranging from 1.7-3.6%.



  • Most common cause is vitamin deficiency: 65% vitamin B12; 12% combined folate/vitamin B12; 6% folate.



  • Pernicious anemia is less common: 1 in 7500 people in USA develops pernicious anemia each year.



  • Prevalence increases with advanced age and in countries with higher rates of malnutrition.





Perioperative Risks





  • Risk of severe anemia and coagulopathy.



  • Risk of coronary, cerebral ischemia secondary to severe anemia.



  • Increased plasma volume as compensatory mechanism can predispose pts to CHF.





Perioperative Risks





  • Risk of severe anemia and coagulopathy.



  • Risk of coronary, cerebral ischemia secondary to severe anemia.



  • Increased plasma volume as compensatory mechanism can predispose pts to CHF.





Worry About





  • Exaggerated effect of myocardial depression from anesthesia.



  • Preoperative treatment should include supplementation of B12 and folate or transfusion in setting of severe anemia and emergent surgery.



  • Decreased platelet count and coagulopathy.



  • Anemia causing MI, stroke, or resp failure.





Overview





  • An anemia caused by a failure of DNA synthesis which results in large, structurally abnormal and immature red blood cells called megaloblasts (MCV >100 fL/cell).



  • Often WBC and platelet counts are also decreased.



  • Anemia develops insidiously and due to physiologic compensatory mechanisms it may not cause symptoms until it is severe.



  • Symptoms: Fatigue, pallor, dyspnea on exertion, headache, dizziness, tachycardia, nausea, diarrhea, glossitis, and jaundice.



  • Vitamin B12 deficiency can interfere with myelination and produce peripheral neuropathy which varies from subtle loss of vibratory sensation and proprioception to frank dementia.





Treatment





  • The treatment of megaloblastic anemia depends upon the underlying cause of the disorder.



  • Diagnose with complete blood counts, red cell indices, and assays of the vitamin B12 and folate.



  • Dietary insufficiency of cobalamin and folate can be treated with appropriate changes to the diet and the administration of supplements.



  • Vitamin B12 1000-2000 μg orally can be given once per d but if pts have neurologic signs, vitamin B12 1 mg IM is usually given 1 to 4 times/wk for several wk.



  • Folate 400-1000 μg orally once per d.



  • Vitamin B12 deficiency must be ruled out before treating with folate alone as this would treat anemia but not the neurologic manifestations.


Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Sep 1, 2018 | Posted by in ANESTHESIA | Comments Off on Anemia, Megaloblastic

Full access? Get Clinical Tree

Get Clinical Tree app for offline access